Literature DB >> 8957377

No-react detoxification process: a superior anticalcification method for bioprostheses.

A Abolhoda1, S Yu, J R Oyarzun, K R Allen, J R McCormick, S Han, F W Kemp, J D Bogden, Q Lu, S Gabbay.   

Abstract

BACKGROUND: Glutaraldehyde pretreatment of bioprosthetic heart valves is the major pathogenic factor in their calcific degeneration. This comparative study investigates the merit of the No-React aldehyde detoxification process as an alternative modifier of xenograft tissues.
METHODS: Glutaraldehyde- and No-React-pretreated porcine aortic valve cusps were implanted subcutaneously in 6-week-old rats (n = 20). At 3, 6, and 14 weeks, randomly selected animals were sacrificed and the explants underwent mineral and morphologic analyses. Glutaraldehyde- and No-React-treated bovine pericardium and porcine aortic valve cusp were incubated in fibroblast cell culture plates. Cell viability was observed under reversed microscope at 6, 24, 48, and 96 hours. Erythrosin B dye exclusion test was used to validate percent cell death.
RESULTS: Pretreatment with No-React significantly inhibited calcification of aortic cusp subcutaneous implants throughout the 14-week period (mean tissue Ca2+ content = 1.3 +/- 0.7 micrograms/mg at 14 weeks.) Glutaraldehyde-treated cusps underwent protracted calcification (Ca2+ content = 190.6 +/- 89.5 micrograms/mg; p < 0.01). Morphologic findings correlated with mineral analyses. One-hundred percent of fibroblast cells survived in the presence of No-React-treated tissue, with a growth pattern indistinguishable from control cell culture (ie, in the presence of no tissue). The cells incubated with glutaraldehyde-treated tissue showed signs of nonviability by 6 hours, with 100% cell death by 48 hours. Dye exclusion tests validated these findings.
CONCLUSIONS: The No-React detoxification process completely abolishes the cytotoxicity of the xenograft tissue and inhibits calcific degeneration.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8957377     DOI: 10.1016/s0003-4975(96)00948-4

Source DB:  PubMed          Journal:  Ann Thorac Surg        ISSN: 0003-4975            Impact factor:   4.330


  3 in total

1.  Early and mid-term results of the Shelhigh stentless bioprosthesis in patients with active infective endocarditis.

Authors:  Michele Musci; H Siniawski; C Knosalla; O Grauhan; Y Weng; M Pasic; R Meyer; R Hetzer
Journal:  Clin Res Cardiol       Date:  2006-04-10       Impact factor: 6.138

2.  Totally biological composite aortic stentless valved conduit for aortic root replacement: 10-year experience.

Authors:  Manuel Galiñanes; Ayo Meduoye; Ignacio Ferreira; Andrzej Sosnowski
Journal:  J Cardiothorac Surg       Date:  2011-06-23       Impact factor: 1.637

3.  Suitability of the rat subdermal model for tissue engineering of heart valves.

Authors:  Torsten Christ; Pascal M Dohmen; Sebastian Holinski; Melanie Schönau; Georg Heinze; Wolfgang Konertz
Journal:  Med Sci Monit Basic Res       Date:  2014-12-10
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.